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ORIGINAL ARTICLE
Safety and Acceptability of Community-Based Distribution
of Injectable Contraceptives: A Pilot Project in Mozambique
Ana Jacinto,a Mahomed Riaz Mobaracaly,a Momade Bay Usta´b,b Cassimo Bique,b Cassandra Blazer,c
Karen Weidert,c Ndola Pratac
Trained community health workers, including traditional birth attendants (TBAs), safely and effectively
administered injectables in northern Mozambique; two-thirds of the women choosing injectables had
never used contraception before. Including TBAs in the Ministry of Health’s recent task sharing strategy
can improve rural women’s access to injectables and help meet women’s demand for contraception.
ABSTRACT
Mozambique has witnessed a climbing total fertility rate in the last 20 years. Nearly one-third of married women have
an unmet need for family planning, but the supply of family planning services is not meeting the demand. This study
aimed to explore the safety and effectiveness of training 2 cadres of community health workers—traditional birth
attendants (TBAs) and agentes polivalentes elementares (APEs) (polyvalent elementary health workers)—to administer
the injectable contraceptive depot-medroxyprogesterone acetate (DMPA), and to provide evidence to policy makers on
the feasibility of expanding community-based distribution of DMPA in areas where TBAs and APEs are present. A total of
1,432 women enrolled in the study between February 2014 and April 2015. The majority (63% to 66%) of women in the
study started using contraception for the first time during the study period, and most women (over 66%) did not report
side effects at the 3-month and 6-month follow-up visits. Very few (less than 0.5%) experienced morbidities at the
injection site on the arm. Satisfaction with the performance of TBAs and APEs was high and improved over the study
period. Overall, the project showed a high continuation rate (81.1%) after 3 injections, with TBA clients having
significantly higher continuation rates than APE clients after 3 months and after 6 months. Clients’ reported willingness to
pay for DMPA (64%) highlights the latent demand for modern contraceptives. Given Mozambique’s largely rural
population and critical health care workforce shortage, community-based provision of family planning in general and of
injectable contraceptives in particular, which has been shown to be safe, effective, and acceptable, is of crucial
importance. This study demonstrates that community-based distribution of injectable contraceptives can provide access
to family planning to a large group of women that previously had little or no access.
INTRODUCTION
Mozambique has witnessed a climbing total fertilityrate in the last 20 years despite declining fertility
rates in the East African region. For example, the fertility
rate increased from 5.2 in 1997 to 5.9 at the time of the
most recent Demographic and Health Survey (DHS) in
2011.1,2 Just over 11% of women in union and 30% of
unmarried women were using modern contraception in
2011, although knowledge of at least one contraceptive
method was universal.1 Modern contraceptive use ap-
pears to be strongly correlated with higher wealth and
education, as well as urban residence. For instance, 3% of
women in the lowest wealth quintile were currently
using modern family planning methods at the time of
the survey, compared with 30% in the highest quintile,
and only 5% of women with no education were using
modern contraception compared with 31% of those who
had reached the secondary level or more. Only 7% of
women in rural areas were using modern contraception
compared with 21% of women in urban areas. Further-
more, nearly one-third of married women inMozambique
have an unmet need for family planning. The supply
and distribution of family planning services and
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contraceptives did not meet demand, as 40.1%
of women surveyed expressed a desire for any
method of contraception, with only 29% of
demand met.1 The preferred method for future
contraceptive use—according to DHS data from
2003 when this indicator was last measured—
was injectable contraceptives, for more than
42% of women of reproductive age.3 However, only
4.3% of all women were using injectable contra-
ceptives in 2011, suggesting an unmet need.1
Access to contraception itself increases use.4
In Mozambique, rural women find themselves
cut off from access to family planning services due
to a shortage of health facilities.5 In 2011, 77% of
family planning services were delivered through
the public health system.1 Family planning ser-
vices and counseling are typically provided through
health facilities, and skilled providers are histori-
cally the gatekeepers of those services. Evidence
from the past decade, however, shows that com-
munity health workers (CHWs) are making key
advances to increase access to injectables in other
sub-Saharan African countries.6-11 Although im-
plants recently surpassed injectables as the fastest-
growing method of contraception in sub-Saharan
Africa,12 injectables are still the most commonly
used method among married women in the
region13; the ease of use and convenience of access
at the community level is likely a contributing
factor.
Community-based distribution (CBD) of
injectables by trusted CHWs may be an effective
approach to increasing family planning use in
rural Mozambique quickly, given the success of
CHWs in countries with similar barriers to access.
The Mozambique Ministry of Health (MOH) ap-
proved the revitalization of the national CHW
program in 2010 in recognition of the critical
importance of CHWs to expand access to basic
primary health care services to communities.14
Some CHWs, called agentes polivalentes elementares
(APEs) (polyvalent elementary health workers),
focus on improving the health of the community
primarily through health promotion and preven-
tion activities. They serve as a linkage between
communities and health facilities, and they pro-
vide community case management for HIV/AIDS,
maternal care, nutrition, and acute illness among
children (diarrhea, malaria, and respiratory infec-
tions). Historically, APEs have not provided
family planning services, although some APEs
provided contraceptives informally. In 2016, APEs
will offer a new package of services that includes
provision of pills, condoms, and injectables.15
In December 2013, the MOH trained 2,270 APEs
on this new family planning package.16
Mozambique’s Family Planning Strategy
2010–2014 was released at the same time the
APE program restarted. The MOH recognized the
need for community involvement and participa-
tion to improve universal access to family plan-
ning services and committed to improving access
through CHWs. The strategy also addressed
the potential role of traditional birth attendants
(TBAs) in the provision of family planning coun-
seling and select methods.18,19 This was an impor-
tant inclusion because TBAs often live in poor,
rural areas that are far from health facilities, and
they have direct access to women during labor,
delivery, and the postpartum period. They may be
therefore uniquely suited to providing injectables
in communities. They can serve as a bridge to the
formal health system and effectively convey infor-
mation to women in culturally appropriate ways.20
Very few studies have assessed TBAs as family
planning providers in sub-Saharan Africa, and
these studies showed mixed results.21-23 A pilot
study conducted in Senegal, however, successfully
included matrones, or trained TBAs, to distribute
injectables.22
Although policy makers are supportive of CBD
in Mozambique, there is limited country-specific
experience on best practices, so stakeholders have
called for operations research in Mozambique.
In response to the call for more research, we con-
ducted this study to determine whether APEs and
TBAs could safely and effectively administer the in-
jectable contraceptive depot-medroxyprogesterone
acetate (DMPA), with high client acceptability,
among women in 2 rural districts.
INTERVENTION AND SETTING
From February 2014 to April 2015, Pathfinder
International implemented a pilot study on the
distribution of DMPA by both APEs and TBAs—in
partnership with the Mozambican Society of
Obstetricians and Gynecologists and the Bixby
Center for Population, Health, and Sustainability.
The study was conducted in 2 districts in north-
ern Mozambique, Chiure and Montepuez, which
are located in the Cabo Delgado Province, where
in 2011, only 2.9% of married women were using
contraceptives, with just 0.8% using injectable
contraceptives.1 The intervention was designed so
that TBAs served clients in Montepuez and APEs
served clients in Chiure.
In 2003, the
preferred method
for future
contraceptive use
was injectable
contraceptives. In
2011, however,
only 4.3% of
women were
using this method,
suggesting an
unmet need.
Access to
contraception
itself will increase
use. In
Mozambique,
however, rural
women lack
access to
contraception due
to a shortage of
health facilities.
Evidence from
other countries
shows that
community health
workers may help
bridge this gap.
Recognizing the
important role of
CHWs,
Mozambique
revitalized a
national program
in which CHWs
will offer
contraception
beginning in
2016.
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Selection, Training, and Supervision of
Community Health Workers
All 25 APEs that had worked in the Chiure district
since 2009 were selected to participate in the
study. Only 8 of the 25 APEs were women. The
predominance of male APEs in this study reflects
the APE program in general, which is 71% male.17
This gender imbalance is likely a result of the
government requirement that APEs should have
completed at least grade 7 to participate in the
program. APEs in Mozambique receive general
training on health care prevention. Their roles
and responsibilities in the communities they serve
include health promotion, provision of vitamin A,
deworming, malaria testing and administration of
malaria medication, and antenatal care sensitiza-
tion. APEs are not officially part of the MOH,
although they receive a stipend of 1,200 meticais
(US$19) per month from the government as com-
pensation for their participation in the program.
External partners provide all funding for the
program including the stipend.15,17
The 34 TBAs who participated in the study were
registered with the MOH and worked collabora-
tively with the health facilities in the Montepuez
district. All 34 TBAs were women. TBAs participate
in a nationally recognized training program that
includes hygienic management and infection con-
trol; recognition of danger signs for referral, post-
partum, and umbilical cord care; and mobilizing
communities to use general preventive health care
services.20 The TBAs were not paid for their parti-
cipation in the study and in general do not receive
any formal compensation for the work they per-
form in the community. However, they do receive
informal monetary and in-kind contributions from
women in exchange for their services. All partici-
pating TBAs were literate, which was necessary for
study recordkeeping.
Both APEs and TBAs received standardized
training before the study began. Five physicians
conducted a 10-day training composed of 3 stages.
Stage 1 included classroom training on topics such
as family planning methods and counseling, study
protocol, recruitment and screening requirements,
injection administration, infection prevention, and
reporting procedures. APEs and TBAs were trained
on how to counsel women on all family planning
methods to promote informed choice. However,
because the providers (APEs and TBAs) would
administer only injectables, the clinical aspects of
the training focused on determining clients’ eligi-
bility for DMPA and administering the injection.
The providers also distributed condoms and
received training on promoting dual protection
against both unintended pregnancy and sexually
transmitted infections (STIs) including HIV.
After completing the classroom training, pro-
viders enrolled in stage 2, a practicum on injec-
tion administration. All providers practiced giving
injections until they felt confident. They were
considered qualified to administer injections after
passing a test in which they provided an injection
to a volunteer.
Stage 3 of the training involved a 1-week
practicum at a health facility in their catchment
area. During the practicum, providers were res-
ponsible for administering informed consent to
clients; completing medical screening for DMPA;
enrolling participants and assigning a client num-
ber; completing the enrollment questionnaire;
providing contraceptive counseling, and adminis-
tering DMPA with a plan for reinjection. This was
done at the health facility under supervision of
the physicians leading the training and nurses in
the facilities before the study began.
There were 3 levels of supervision provided
during the study implementation:
1. In the first level of supervision, 18 trained
nurses (1 per facility in the catchment area)
oversaw data collection and clinical super-
vision. Nurse supervisors were responsible for
confirming completion of the enrollment
questionnaire filled out by the study providers
and for addressing any clinical issues that
arose during the course of the study.
2. The province coordination team provided a
second level of supervision on a monthly basis
to ensure that nurse supervisors performed
their responsibilities as detailed in the study
protocol, including timely administration of
the 3-month and 6-month follow-up ques-
tionnaires to clients.
3. The study investigators provided a third level
of supervision on a quarterly basis by review-
ing all components of the project including
data entry and management.
METHODS
The study was a prospective non-randomized
community intervention trial designed to assess
the safety, acceptability, and effectiveness of the
provision of DMPA by APEs and TBAs as well as
continuation outcomes among clients of both
providers. The study design was based on earlier
CHWs participated
in a 10-day
standardized
training program
that covered all
contraceptive
methods,
recruitment and
screening
requirements, and
injection
administration of
DMPA.
Traditional birth
attendants may be
uniquely suited to
providing
injectables in rural
communities
because they
often live in poor,
rural areas and
have direct access
to women during
labor, delivery,
and the
postpartum
period.
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successful pilot studies in Ethiopia and Uganda.7,9
By building upon these study designs, we hoped
to provide a mechanism for standardizing data
across countries. In the case of clinical research,
standardization has been shown to increase data
quality, improve data integration and reusability,
and enable facilitation of data exchange with
partners.24
Safety, acceptability, effectiveness, and con-
tinuation rates were the outcomes of interest.
We compared these outcome rates among clients
who received DMPA from APEs and clients who
received DMPA from TBAs. We based the sample
size of 1,000 women on the need to test for non-
inferiority of the services provided by the 2 types
of providers. We assumed a continuation rate of
65% after first injection among APE clients and a
continuation rate of at least 55% among TBA
clients (for a maximum difference of 10% between
groups) as being equivalent. We also assumed a
loss to follow-up of 20%, a design effect of 2.0, and
similar recruitment rates in all districts.
All women of reproductive age in the com-
munity were made aware of the project through
existing community meetings led by CHWs and
given the opportunity to request DMPA from a
community provider assigned to their district.
Those who wished to receive DMPA from an APE
or TBA were recruited for the study. Members of
the study team met with potential participants
and obtained informed consent prior to enroll-
ment in the study. Providers screened each
participant for eligibility to receive DMPA using
a tool and manual developed by FHI 360 and
based on World Health Organization recommen-
dations. 25 Women who were medically ineligible
or did not want to participate in the study were
referred to the nearest health facility. Participants
did not receive any compensation, but they
received DMPA free of charge during the study.
Participants were asked to complete 3 orally
administered questionnaires: 1 at enrollment (first
injection), 1 at a follow-up visit after 3 months
(13 weeks, second injection), and 1 at a follow-up
visit after 6 months (26 weeks, third injection).
The questionnaires were first developed in
English and then translated into Portuguese.
The data collected included sociodemographic
characteristics, satisfaction with DMPA as a
method, satisfaction with the provider, quality
of the services provided, knowledge of and
experience with side effects, reasons for discon-
tinuing the injections, and willingness to pay for
injectables.
We entered the data in Epi Info (version
7.1.4.0) and conducted the analysis with Stata
(version 13). The results presented in this article
include information generated through fre-
quency and cross-tabulations. We assessed differ-
ences in responses between the APE clients and
TBA clients using chi-square tests for association
among categorical variables and t tests for inde-
pendent samples to determine differences be-
tween the client group means. Discontinuation
and continuation rates overall and by provider
were estimated over time from the first injection to
the second injection and from the first injection to
the third injection. We estimated continuation,
discontinuation, and lost-to-follow-up rates using
data from the questionnaires at 3 months and
6 months. Women who reported receiving their
second and third injections represent continuation
at 3 months and at 6 months, respectively. Discon-
tinuation during this same period was estimated if
a woman reported in her 3-month and 6-month
questionnaire that she did not receive her second
or third injection. Lost to follow-up was estimated
for women who completed the enrollment ques-
tionnaire, but for whom both the 3- and 6-month
questionnaires were absent.
Ethical approval for this project was grant-
ed by the Committee for Protection of Human
Subjects at the University of California, Berkeley
(CPHS # 2012-06-4460) and from the Mozambique
Ministry of Health Comite de bioetica para a saúde
(IRB00002657, Ref: 197/CNBS/13).
RESULTS
A total of 1,432 eligible women enrolled in the
study between February and November 2014.
TBAs recruited 782 women and APEs recruited
649 women for the study. The summary of enroll-
ment and follow-up data is illustrated in Figure 1.
At the 3-month follow-up visit, 1,242 women
participated in the questionnaire; 48 women
refused to respond to the questionnaire, resulting
in a response rate of 96%. At the 6-month visit,
1,264 women responded to the questionnaire,
with a response rate of 98.6%; this included
22 women who refused the 3-month question-
naire, and were therefore assumed lost to follow-
up. These 22 women were asked about their
second injection; if they received it, they were
added to the continuation rates.
Table 1 outlines demographic and other key
indicators for the 1,432 women who enrolled in the
study. Clients of APEs and TBAs were statistically
Building on the
study design of
two successful
pilot studies, we
sought to provide
a mechanism to
standardize data
across countries.
The 1,432 women
who enrolled in
the study had a
high response rate
to questionnaires
given at the
3-month visit and
the 6-month visit—
96% and 98.6%,
respectively.
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similar on most variables. Although most clients
in both groups reported no education, clients of
APEs had significantly less education than clients
of TBAs.
Table 2 describes the rates of discontinuation
and loss to follow-up by group–APE clients and
TBA clients. Discontinuation rates were estimated
for 2 time frames: (1) between enrollment and
the second injection; and (2) between enrollment
and the third injection. Overall, the continuation
rate was high (81.1%) in both groups after
3 injections, with TBA clients having significantly
higher continuation rates both at 3 months and
at 6 months. Loss-to-follow-up rates were 13.8%
for the entire project period between enrollment
and the third injection at 6 months; however,
APE clients had 20.8% loss to follow-up compared
with 7.8% among TBA clients. For APE clients,
the most common reason given for discontinua-
tion at 3 months (50.6%) and 6 months (53.6%)
was that the woman was planning to get her
injection but had not yet reached the provider to
receive it. Both TBAs and APEs provided injec-
tions at their own home, their client’s home, or
another place in the community as determined by
the provider and client. TBA clients were more
likely to state ‘‘other reasons’’ without explaining
why they missed injections at both 3 months and
at 6 months (data not shown).
The majority of women enrolled in the study
had never used a contraceptive method before
(63% of TBA clients and 66% of APE clients).
Approximately 30% of all clients reported previous
use of DMPA. Figure 2 provides details on previous
types of methods used.
More than 60% of both APE and TBA clients
reported duration of effectiveness as the reason
why they preferred DMPA. About 29% of TBA
clients and 20% of APE clients reported that they
chose to use DMPA because their husbands per-
mitted this method. Additionally, nearly 10% of
TBA clients reported that they chose DMPA for
the convenience, and 24.2% of APE clients liked
DMPA because there were ‘‘fewer side effects’’
(data not shown).
APE clients reported receiving more counseling
than TBA clients on both side effects and STIs
including HIV. However, the percentage of clients
who reported receiving counseling on side effects
and STIs improved between the 3-month and the
6-month follow-up visits in both groups (Figure 3).
The percentage of APE clients who reported being
offered condoms in addition to DMPA was also
higher than TBA clients. At 3 months, 31% of TBA
clients and 48% of APE clients reported being offered
condoms. At 6 months, those percentages were
21.3% and 54.8%, respectively (data not shown).
Most clients reported no side effects from DMPA
at both the 3-month and 6-month follow-up visits
(Figure 4). At 3 months, less than 10% of women
reported experiencing amenorrhea, spotting, heavy
bleeding, or irregular bleeding. Fewer side effects
were generally reported at 6 months than at the
3-month time point. Less than 0.5% of women re-
ported any morbidities at the injection site, including
induration or abscess (data not shown).
FIGURE 1. Summary of Client Enrollment and Follow-Up
The continuation
rate was high
(81.1%) in both
groups after
3 injections, with
TBA clients having
significantly
higher
continuation rates
both at 3 months
and at 6 months.
APE clients
reported receiving
more counseling
on side effects and
STIs including HIV
than TBA clients.
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The majority of women were satisfied with
both the method and their provider. Among TBA
and APE clients, 74.7% and 88.2%, respectively,
were satisfied with DMPA at 3 months. At
6 months, 90.1% of TBA clients and 89.2% of
APE clients reported satisfaction with the method
(data not shown). At 3 months, 73.7% of TBA
clients and 89.1% of APE clients reported satis-
faction with their provider. At 6 months, reported
client satisfaction with the provider improved to
89.8% among TBA clients and 94.1% among APE
clients (data not shown).
Overall, 64% of women in the study reported
that they were willing to pay for DMPA, but TBA
clients were much more willing to pay than APE
clients (data not shown). For women in both
client groups, the mean amount they were willing
to pay was approximately 34 meticais (US$0.93).
At the 3-month visit, the mean amount that
women were willing to pay was about 39 meticais
(US$1.07) and 5 meticais (US$0.13) among TBA
clients and APE clients, respectively. At the
6-month visit, women were willing to pay 40
meticais ($1.10) and 7 meticais ($0.19), respec-
tively (data not shown).
DISCUSSION
Although CBD of injectable contraceptives is no
longer a novel idea in sub-Saharan Africa, the
process of translating community-based health
care policies into effective programs is not always
straightforward. For example, policy makers in
Mozambique were supportive of CBD, but there
was limited country-specific experience and no
country-level data to support the policy. Conse-
quently, this study generated evidence to support
CBD of DMPA in northern Mozambique and
TABLE 1. Background Characteristics of Enrolled Women, by Provider (N = 1,431)
TBA Clients
(n=782)
APE Clients
(n=649)
Age at enrollment, years, mean (SD) 29.3 (6.9) 29.9 (7.6)
No. of living children, mean (SD) 4.2 (2.1) 4.8 (2.6)
Marital status, No. (%)
Married/living together 655 (83.8) 539 (83.1)
Single, never married 52 (6.7) 52 (8.0)
Divorced/separated/widowed 64 (8.2) 40 (6.2)
Education, No. (%)
None 488 (62.4) 472 (72.7)*
Only read and write 38 (4.9) 49 (7.6)
Primary 246 (31.5) 177 (18.0)*
Secondary or higher 6 (0.8) 6 (0.9)
Husband supportive of using DMPA, No. (%)
Yes 614 (78.5) 526 (81.1)
No 47 (6.0) 46 (7.1)
Husband not aware 28 (3.6) 16 (2.5)
Not married/does not know 70 (9.0) 48 (7.4)
Abbreviations: APE, agente polivalente elementare (polyvalent elementary health worker); DMPA, depot-
medroxyprogesterone acetate; SD, standard deviation; TBA, traditional birth attendant.
Note: Percentages include missing, not shown. One client of the total recruited was missing provider information.
* Po.05 for comparison of TBA vs. APE.
The majority of
women in the
study were willing
to pay for DMPA
(64%), with TBA
clients much more
willing to pay than
APE clients.
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TABLE 2. Discontinuation and Loss to Follow-Up, by Provider (N =1,432)
Second Injection Third Injection
Total After 3
Injections
TBA
Clients APE Clients TBA Clients APE Clients All Clients
Received injection, No. (%) 627 (80.2) 442 (68.1)* 716 (91.6) 445 (68.6)* 1,161 (81.1)
Discontinued, No. (%)
(did not receive injection)
11 (1.4) 89 (13.7)* 5 (0.006) 69 (10.6)* 74 (5.2)
Lost to follow-up, No. (%)
(includes missing data)
144 (18.4) 118 (18.2) 61 (7.8) 135 (20.8)* 197 (13.8)
Total number of clients at
enrollment
782 649 782 649 1,432
Abbreviations: APE, agente polivalente elementare (polyvalent elementary health worker); TBA, traditional birth attendant.
Note: Percentages include missing, not shown. One client of the total recruited was missing provider information.
* Po.05 for comparison of TBA vs. APE.
FIGURE 2. Previous Use of Contraception Among Study Population, by Provider Type (N=1,432)
Abbreviations: APE, agente polivalente elementare (polyvalent elementary health worker); DMPA, depot-
medroxyprogesterone acetate; IUD, intrauterine device; TBA, traditional birth attendant.
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found that provision of injectable contraceptives
by APEs and TBAs was feasible, safe, effective,
and acceptable among women. Very few morbid-
ities at the injection site and no deaths were
reported. The study demonstrated that APEs and
TBAs can improve contraceptive access and use in
rural Mozambican communities; in fact, the
majority of women in the study started using
contraception for the first time during the study
period, and satisfaction with community-based
providers was high and improved over the entire
study period.
Continuation rates in both clients groups
were high overall and similar to rates found in
other pilot studies on CBD of DMPA in Kenya and
Ethiopia.7,11 Interestingly, TBA clients had sig-
nificantly higher continuation rates than APE
clients. This difference could indicate a gender
barrier in the program because the majority of
APEs were men and all TBAs were women;
however, we believe it suggests that TBAs have a
critical role in linking women to reproductive
health services at the community level. For
example, TBAs are involved in initiation rituals
that take place before women become sexually
active in Cabo Delgado, the province included in
this study, and TBAs are also considered advisors
for sexual and reproductive health in many rural
communities in Mozambique. The high continua-
tion rates among TBA clients might indicate that
TBAs can conduct more rigorous client follow-up
compared with APEs, or it may be that women
interact with their TBAs more regularly.
Women may also place more trust in their
TBAs, or have higher satisfaction with TBAs as a
family planning provider. Nearly 17% of births in
the country in the 5 years preceding the most
recent 2011 DHS were assisted by a TBA,1 which
is up from 11% in 2003.3 This suggests that
women and TBAs have an important relationship
in Mozambique.
This study confirms previous findings that
TBAs are uniquely poised to address critical gaps in
postpartum contraceptive uptake.22,26 This is an
important finding given that postpartum women
are among those with the greatest unmet need for
family planning and often do not receive family
planning services.27 In fact, a previous analysis of
DHS data from 27 low- and middle-income coun-
tries found that although 95% of postpartum
women wanted to avoid a pregnancy within the
next 2 years, only 30% were using contraception.28
Our study generated pivotal evidence to support
the inclusion of TBAs in delivery of injectable
FIGURE 3. Percentage of Women Counseled on Side Effects and STIs Including HIV at Follow-Up
Visits, by Provider (N=1,432)
Abbreviations: APE, agente polivalente elementare (polyvalent elementary health worker); STI, sexually transmitted infection;
TBA, traditional birth attendant.
Global Health: Science and Practice 2016 | Volume 4 | Number 3 417
CBD of Injectables in Mozambique www.ghspjournal.org
contraceptives. However, future research is needed
to understand the important linkage between
TBAs as family planning providers and high con-
traceptive continuation rates among their clients.
Future qualitative research into women’s gender
preference among providers may also illuminate
some of the differences between continuation
results of APEs and TBAs.
In addition to recognizing the advantages of
including TBAs in family planning, it is important
to address the challenges surrounding limited STI
counseling related to TBA provision of services.
TBAs provided substantially less STI counseling
(36%) than APEs (70%) did at the 3-month follow-
up visit, and only slightly improved at 6 months
(45%). TBAs were also less likely to offer condoms
in addition to DMPA for dual protection. Consider-
ing their lower education levels compared with
APEs, and relative inexperience with trainings,
TBAs may require additional support to provide
these services consistently and adequately. Find-
ings from a recent systematic review found a
moderate increased risk of HIV among women
using DMPA in the general population.29 With an
HIV prevalence of 11.1% in Mozambique,30 HIV
counseling and dual protection should be prior-
itized in future trainings, and TBAs should receive
regular refreshers that emphasize the importance
of these issues.
APE clients reported receiving more STI
counseling than TBA clients; however, the low
rates of reported side effects among all clients
may indicate the quality of TBAs’ counseling on
side effects, and may also have influenced con-
tinuation rates. Typical side effects associated
with DMPA use were reported at lower rates (10%
at 3 months) in this study than in similar studies
in Ethiopia and Uganda, where approximately
FIGURE 4. Reported Side Effects Following Second and Third Injections of DMPA, by Provider
(N=1432)
Abbreviations: APE, agente polivalente elementare (polyvalent elementary health worker); DMPA, depot-
medroxyprogesterone acetate; TBA, traditional birth attendant.
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20% to 30% of women reported side effects.7,9 It is
difficult to draw conclusions without additional
research into the quality of services and percep-
tions of clients. Results of research on side effects
and continuation have been mixed and both
individual characteristics of the users and ser-
vice delivery factors have been shown to affect
both reporting of side effects and continuation.31
Nonetheless, several studies have found that both
providers’ attitudes and the information they
provide may influence a woman’s perception of
bleeding.31-33
Women’s overall willingness to pay for DMPA
(64%) is also noteworthy and highlights the
demand for injectable contraceptives among
Mozambican women as well as an opportunity for
scaling up CBD in Mozambique. Although donors
contribute more than 50% of the country’s total
budget for health, with the United Nations
Population Fund (UNFPA) and the U.S. Agency
for International Development (USAID) purchas-
ing Mozambique’s contraceptive supplies,19 this
may not always be the case. Cost recovery ap-
proaches for contraceptive delivery may therefore
be necessary in the future, even though they are
not currently in place in the public sector. TBA
clients were more willing to pay for injectable
contraceptives than APE clients, which may be
related to women’s expectations. Trained TBAs
have reported informal compensation, both in-
kind and monetary, for births that they have
attended,20 whereas APE services are paid for by
the government and free to the client. Conse-
quently, TBA family planning clients might be
more comfortable with family planning user fees.
Limitations
In this study, 197 women (14%) were lost to
follow-up, and therefore it cannot be determined
whether these women discontinued use of DMPA.
Additionally, verification of DMPA injection was
completed at the 3- and 6-month follow-up visits.
Even among women who were not lost to follow-
up, the response rate was not 100%. Women who
refused to respond to the questionnaire were not
captured in the continuation and discontinuation
rates, with the exception of the 22 women who
refused the 3-month questionnaire but accepted
the 6-month questionnaire (Figure 1). The lost to
follow-up total does include women who were
interviewed, but did not have recorded data about
whether they received DMPA. The number of
women without data was small (9 women for the
3-month questionnaire and 1 woman for the
6-month questionnaire).
CONCLUSION
Given Mozambique’s largely rural population and
critical health care workforce shortage, a reliance
on safe, effective, and acceptable community-
based family planning provision is of crucial
importance. Evidence-based strategies should
guide programmatic implementation. In the case
of Mozambique, 2 strategies could be adopted
based on evidence generated through this study:
(1) TBAs should be included as community-based
distributors of family planning services; and
(2) public-sector programs should include client
fees based on willingness to pay and/or allow for
revitalization of private-sector distribution of
contraceptives in rural areas. This study demon-
strated that CBD of injectables can provide access
to a large group of women that previously had
little to none, considering the tremendous pro-
portion of women using contraception for the
first time during this study. More importantly, it
also highlighted the central role that TBAs can
play in a context similar to rural Mozambique. In
regions where the fertility rate is high, births are
too closely spaced, and women face innumerable
obstacles in reaching health facilities, TBAs can
provide family planning services that promote
healthy timing of pregnancies with high con-
tinuation rates. To meet the contraceptive desires
of vulnerable women, policy makers and program
staff should consider CBD of injectables, espe-
cially models where TBAs are trained and trusted
to provide safe and acceptable ongoing care.
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